REGN
Regeneron Pharmaceuticals Inc
784.90$
-0.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 7.3% | 9.6% | 6.2% | 6.8% | 6.5% | 9.9% | 16.0% | 16.9% | 14.0% | 6.7% | 13.9% | 14.6% | |
| 92.7% | 90.4% | 93.8% | 93.2% | 93.5% | 90.1% | 84.0% | 83.1% | 86.0% | 93.3% | 86.1% | 85.4% | |
| 45.1% | 39.5% | 42.2% | 35.3% | 32.6% | 38.6% | 29.4% | 16.3% | 25.1% | 33.8% | 36.8% | 40.8% | |
| 17.9% | 20.4% | 24.2% | 22.5% | 23.2% | 23.3% | 15.8% | 11.4% | 17.4% | 19.5% | 20.8% | 18.8% | |
| 63.0% | 59.9% | 66.5% | 57.8% | 55.8% | 62.0% | 42.0% | 27.4% | 41.7% | 53.9% | 58.0% | 60.4% | |
| 29.7% | 30.5% | 27.4% | 35.4% | 37.8% | 28.1% | 42.1% | 55.7% | 44.2% | 30.9% | 28.1% | 24.9% | |
| 1.3% | 0.3% | 0.1% | 0.4% | 0.4% | 0.4% | 0.7% | 0.4% | 0.5% | 0.6% | 0.4% | 0.3% | |
| 27.5% | 29.9% | 27.4% | 35.4% | 38.1% | 30.9% | 44.8% | 58.0% | 39.9% | 32.0% | 33.7% | 36.5% | |
| 15.2% | 14.4% | 8.9% | 15.0% | 1.6% | 4.0% | 3.5% | 7.8% | 4.3% | 1.9% | 2.6% | 5.1% | |
| 12.3% | 15.5% | 18.4% | 20.4% | 36.4% | 26.9% | 41.3% | 50.2% | 35.6% | 30.1% | 31.1% | 31.4% | |
| 31.6% | 32.3% | 29.5% | 37.9% | 40.0% | 30.8% | 48.3% | 60.2% | 43.2% | 30.9% | 37.4% | 40.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.